City Hall
1 Dr. Carlton B. Goodlett
Place
San Francisco, CA 94102-
4689
City and County of San Francisco
Legislation Details
File #:
Version:
1
211113
Name:
Hearing - Committee of the Whole - Existing
Litigation - AmerisourceBergen Corp., Cardinal
Health, Inc., and McKesson Corp. - City to Receive
up to $50 Million (File 211071) - Johnson & Johnson
- City to Receive up to $11 Million (File 211072)
Status:
Type:
Hearing
Filed
File created:
In control:
10/26/2021
Board of Supervisors
On agenda:
Final action:
11/2/2021
11/2/2021
Enactment date:
Enactment #:
Title:
Hearing of the Board of Supervisors sitting as a Committee of the Whole on November 2, 2021, at
3:00 p.m., to hold a public hearing to consider the proposed Ordinances (File Nos. 211071 and
211072) regarding existing litigation relating to the partial settlement of the lawsuit filed on behalf of
the City and County of San Francisco and the People of the State of California against three large
distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and
McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over
18 years, entitled The City and County of San Francisco and the People of the State of California v.
Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A.
Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the
Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc.,
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo
Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics,
Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc.
N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson
Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; and
the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the
People of the State of California against Johnson & Johnson and its subsidiary, Janssen
Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over
nine years, entitled The City and County of San Francisco and the People of the State of California v.
Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A.
Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the
Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc.,
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo
Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics,
Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc.
N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson
Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation;
scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No. 211114),
approved on October 26, 2021.
Sponsors:
Attachments:
1. Board Pkt 110221
Action By
Date
Action
Result
Ver.
SCHEDULED FOR PUBLIC HEARING
Clerk of the Board
10/26/2021
1
HEARD AND FILED
Board of Supervisors
11/2/2021
1